Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis. From lesion to symptoms].

P Cesaro1, J D Degos

  • 1Service de neurologie, hôpital Henri Mondor, Créteil.

La Revue Du Praticien
|September 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive RCT in screening, surveillance, and diagnostic AI-assisted colonoscopies (ACCENDO-Colo study).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

AMF communities associated to Vitis vinifera in an Italian vineyard subjected to integrated pest management at two different phenological stages.

Scientific reports·2020
Same author

Metaproteomic characterization of theVitis vinifera rhizosphere.

FEMS microbiology ecology·2018
Same author

Barriers against split-dose bowel preparation for colonoscopy.

Gut·2016
Same author

[Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].

Revue neurologique·2014
Same author

Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD.

Sleep medicine·2011
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Multiple sclerosis symptoms don't always match imaging findings. New insights suggest therapies could restore nerve conduction without directly targeting demyelination in multiple sclerosis.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Context:

  • Clinical manifestations of multiple sclerosis (MS) show poor correlation with imaging, electrophysiology, or anatomical findings.
  • Conduction block in the central nervous system (CNS) white matter can occur independently of demyelination.
  • Demyelinated fibers may still allow for continuous nerve conduction.

Purpose:

  • To explore the mechanisms underlying the discrepancy between MS clinical symptoms and pathological findings.
  • To explain the occurrence of transient neurological deficits and relapses not directly linked to demyelination.
  • To propose therapeutic strategies targeting nerve conduction restoration.

Summary:

  • Clinical symptoms in multiple sclerosis (MS) are not always directly correlated with the extent of demyelination or lesions observed through various diagnostic methods.

Related Experiment Videos

  • Conduction block, a cause of neurological deficits, can occur in the CNS white matter even without demyelination, and demyelinated axons can sometimes maintain conduction.
  • These findings suggest that some MS relapses and transient symptoms may arise from mechanisms other than demyelination, offering new therapeutic avenues.

    • Impact:

    • Provides a framework for understanding the complex relationship between MS pathology and clinical presentation.
    • Suggests that therapies aimed at restoring nerve conduction, rather than solely focusing on remyelination, could be effective in managing MS.
    • Opens new possibilities for treating MS by targeting conduction block mechanisms independent of demyelination.